Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

LC-MS/MS proteomics data for identifying anti-ferroptosis regulators

ABSTRACT: Cytoplasmic and nuclear proteins were extracted from relative ferroptosis-resistant cell (A549) and relative ferroptosis-sensitive cell (Calu-1) with or without the treatment of erastin (10 μM, 10 hours) for LC-MS/MS proteomics analysis to identify potential anti-ferroptosis regulators that entered nucleus from cytoplasm under ferroptosis induction.

ORGANISM(S): Homo Sapiens

SUBMITTER: Jiayi Wang

PROVIDER: PXD072927 | iProX | Sun Jan 11 00:00:00 GMT 2026

REPOSITORIES: iProX

ACCESS DATA

Json Xml

Similar Datasets

IP-MS data for identifying potential ferroptosis-associated and ISG15-related transcription factors

Project description:Nuclear proteins were extracted from relative ferroptosis-resistant cell (A549) with or without the treatment of erastin (10 μM, 10 hours) and immunoprecipitated by anti-ISG15 antibody for LC-MS/MS proteomics analysis to identify potential ferroptosis-associated and ISG15-related transcription factors.

2026-01-09 | PXD072900 |

IP-MS data for identifying oxidation site of YY1 under ferroptosis induction

Project description:Nuclear proteins were extracted from relative ferroptosis-resistant cell (A549) following treating with DMSO or erastin(10 μM, 10 hours) with or without treatment of Fer-1 and immunoprecipitated by anti-YY1 antibody for LC-MS/MS proteomics analysis to identify oxidation site of YY1 under ferroptosis induction.

2026-01-10 | PXD072939 |

RNA-seq of human pancreatic cancer cell line PANC-1 treated with RSL-3, N6F11, Fin56 and Erastin against untreated controls

Project description:Ferroptotic cell death is dependent on unrestricted lipid peroxidation rather than activation of apoptotic effector caspases. A large number of ferroptosis activators have been reported recently. We used gene sequencing to analyze the effects of four ferroptosis activators (RSL3, N6F11, Fin56 and Erastin) on global gene expression in human PDAC1 cell line.

2023-10-18 | E-MTAB-12241 | biostudies-arrayexpress

3D gene regulation network in glioma ferroptosis

Project description:Erastin is a small molecular compound which inhibits the system Xc- and prevents the import of cystine, reducing glutathione (GSH) biosynthesis and glutathione peroxidase 4 (GPX4) activity, and finally inducing cell death via ferroptosis. To establish a model of Erastin induced ferroptosis in glioma cells, U87 cells were treated of Erastin (10 μM, 72 h). Combination analysis of HiChIP, ChIP-seq and RNA-seq data suggests that change of chromatin loops mediated by 3D chromatin structure regulate gene expressions in glioma ferroptosis. Genes that regulated by 3D chromatin structure include genes that were reported function in ferroptosis like MDM2 and TXRND1. We propose a new regulatory mechanism governing glioma cell ferroptosis by 3D chromatin structure.

2023-10-23 | GSE236253 | GEO

Genome-wide analysis of ferroptosis related genes in liver cancer cells.

Project description:To seek ferroptosis related genes in liver cancer cells, we treated HepG2 cells using ferroptosis inducer Erastin and inhibitor Ferrostatin, respectively. We found that a subset of genes were up-regulated in Erastin treatment groups and down-regulated in Ferrostatin treatment groups, suggesting that these genes might be correlated with ferroptosis.

2019-06-10 | GSE104462 | GEO

Effects of nanodelivery system PQR NPs on gene expression regulation in antagonizing erastin-induced PC12 cell damage via ferroptosis

Project description:The coordinated and sequential interactions between drug-loaded nanocarriers and key genes within the cellular ferroptosis pathway are crucial for maintaining the survival and functional stability of PC12 neuronal cells. In this report, we demonstrate that quercetin-loaded PQR NPs serve as a key regulatory vehicle in counteracting Erastin-induced damage to PC12 cells. The absence of PQR NPs markedly heightens PC12 cells' susceptibility to Erastin-induced ferroptosis, a phenomenon reversible through exogenous administration of PQR NPs. Furthermore, PQR NPs interact both physically and functionally with core ferroptosis pathway genes (such as GPX4) and epigenetic modifiers, thereby regulating the expression levels of ferroptosis-related genes during Erastin-induced injury. Although PQR NPs are not essential for the transcriptional activity of core genes themselves, the quercetin delivery and release process mediated by PQR NPs is indispensable for scavenging excess reactive oxygen species within cells, maintaining GPX4 expression stability, and inhibiting Erastin-induced lipid peroxidation. Collectively, our data provide a molecular framework for how nanodelivery systems exert cytoprotective effects by regulating ferroptosis pathway gene expression. In this process, PQR NPs deliver quercetin and modulate the expression balance of key ferroptosis genes, thereby counteracting Erastin-induced damage in PC12 cells.

2026-06-15 | GSE317386 | GEO

Proteomic shift in mouse embryonic fibroblasts Pfa1 during erastin-induced ferroptosis

Project description:This report provides data on ferroptosis induced proteomic response in immortalized mouse embryonic fibroblasts which are 4-OH-TAM-inducible Gpx4−/− (referred to as Pfa1 cells). Pfa1 cells are a valuable, widespread and well characterized model for ferroptosis research. In the first part of this batch, we used Erastin to induce ferroptosis and collected samples at 0h, 24h and 48h after treatment. Untreated cells were used as a control. In the second part, we tested Liproxtatin-1 ferroptosis inhibitor on Tamoxifen-induced Pfa1 cells after 0h, 24h, 48h. Tamoxifen-induced ferroptosis activation of these cells are in PRIDE PXD040094. Pfa1 cells (a kind gift from Marcus Conrad, Munich) were cultured in RPMI-1640 media (2 g/L glucose, 10% FBS, 2 mM Gibco GlutaMAX Supplement, 1% pen/strep) at 37C with 5% CO2 in a humidified incubator. Cells (300k) were seeded on Corning 100 mm tissue-culture treated culture dishes and incubated overnight. On the next day Pfa1 cells were treated with or without 0.5 µM erastin (E7781, Sigma-Aldrich). For experiment on ferroptosis inhibition Pfa1 cells were treated with or without 1 µM Tamoxifen and 0.5 µM Liproxtatin-1 simultaneously.

2023-07-11 | PXD041463 | Pride

Erastin-Induced Ferroptosis Enhances Natural Killer Cell Anti-Tumor Activity and Offers Therapeutic Potential in Neuroblastoma

Project description:High-risk neuroblastoma (NB) often relapses and becomes refractory to treatment, making it a significant contributor to childhood cancer mortality despite its relative rarity. Addressing the challenges posed by NB’s resistance to conventional apoptosis-inducing therapies (e.g., chemotherapy and radiation) has become a pressing concern in pediatric oncology research. In recent years, the growing comprehension of alternative cell death modalities distinct from apoptosis has revealed a promising avenue in the endeavor to combat treatment-resistant cancers. One such mechanism, ferroptosis, has attracted increasing attention for its potential role in combating therapy-resistant cancer cells. High-risk NB typically exhibits an immune-excluded phenotype, characterized by minimal immune cell infiltration. Despite this characteristic, the mechanisms underlying immune exclusion and impaired immune activation in NB remain unclear. Here, we demonstrate that the induction of ferroptosis using Erastin, a cysteine-glutamate antiporter inhibitor, reduces NB cell proliferation and foci formation. Furthermore, our transcriptomics analysis revealed that treatment with Erastin in NB cells led to increased expression of ULBP1, a ligand to the activating natural killer (NK) cell receptor, NKG2D. Upon ferroptosis induction, the transcription factor ATF4 was found to drive ULBP1 expression in NB cells. Consistent with this, pre-treatment with Erastin sensitized NB cells to NK cell cytotoxicity in co-culture experiments. These results suggest the NK cell’s cytotoxic function can be enhanced with Erastin-mediated ferroptosis, which may be beneficial for NB patients.

2026-02-12 | GSE317656 | GEO

HSPA4 restrains transferrin in dopaminergic neurons to attenuate ferroptosis in a Parkinson’s disease model

Project description:Heat shock protein A4 (HSPA4) is a molecular chaperone belonging to the heat shock protein 70 (HSP70) family. This study aims to investigate the antiferroptotic effects of HSPA4 in a Parkinson’s disease (PD) model and explore the underlying mechanisms. Here we show that HSPA4 overexpression reduces ferroptosis in erastin-treated SH-SY5Y cells and primary dopaminergic neurons, while HSPA4 knockdown exacerbates ferroptosis. In MPTP-induced PD model mice, HSPA4 rectifies behavioral defects, prevents the loss of dopaminergic neurons, and alleviates ferroptosis. Mechanistically, HSPA4 interacts with transferrin in the cytoplasm and inhibits its export from the cell. Consequently, extracellular iron cannot be transported into cells due to a lack of transferrin, thereby attenuating ferroptosis in dopaminergic neurons and slowing PD progression. By restraining transferrin in dopaminergic neurons, HSPA4 reduces ferroptosis and alleviates parkinsonism in a PD mouse model. Therefore, HSPA4 might present a potential therapeutic target for the development of PD treatments.

2025-10-20 | PXD067550 | Pride

RNA-seq Analysis of Prostate Cancer Cell Under Erastin Exposure

Project description:In order to investigate which genes with different expression in prostate cancer(PCa) cells(LNCaP and PC3) after erastin exposure, and identify the essential ferroptosis related genes (FRGs) associated with ferroptosis in PCa cell. 5.0µM erastin was added in cell medium, and we performed gene expression profiling analysis using data obtained from RNA-seq of 12 different cells.

2023-09-12 | GSE232034 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data